Sort
11,323 grants matching “glioblastoma”
Regulation of telomere recombination in ALT cancer cells
$376,099Susan Smith · New York University School Of Medicine · R01 · FY2019 · CA
Project 2: Combined personal neoantigen-targeting cancer vaccines with immune checkpoint blockade for ovarian cancer
$376,043Panagiotis Konstantinopoulos · Dana-Farber Cancer Inst · P50 · FY2022 · CA
MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy
$376,000Adam M Sonabend · Northwestern University At Chicago · R01 · FY2023 · NS
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$376,000Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2022 · NS
MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy
$376,000Adam M Sonabend · Northwestern University At Chicago · R01 · FY2022 · NS
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$376,000Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2023 · NS
The mechanisms driving brain oncogenesis by FGFR-TACC gene fusions
$375,952Antonio Iavarone · Columbia University Health Sciences · R01 · FY2014 · CA
Understanding the antagonistic role of proteostasis in Alzheimer disease and cancer.
$375,719Alexander Richard Mendenhall · University Of Washington · R01 · FY2020 · CA
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
$375,710W Mark Saltzman · Yale University · R01 · FY2016 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER
$375,644Sidney Kimmel Cancer Center · R01 · FY2002 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER
$375,644Sidney Kimmel Cancer Center · R01 · FY2001 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER
$375,644Sidney Kimmel Cancer Center · R01 · FY2000 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER
$375,644Sidney Kimmel Cancer Center · R01 · FY2003 · CA
Quantitative Analysis of Epidermal Growth Factor Receptor Signaling Networks
$375,642Forest M White · Massachusetts Institute Of Technology · R01 · FY2010 · CA
Project 3: Sex-specific differences in the tumor microenvironment alter glioblastoma growth
$375,603Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · CA
MR Investigation of IDH Mutation and Its Marker 2-HG in Brain Tumor Patients
$375,455Hui Mao · Emory University · R01 · FY2017 · CA
MR Investigation of IDH Mutation and Its Marker 2-HG in Brain Tumor Patients
$375,455Hui Mao · Emory University · R01 · FY2013 · CA
MR Investigation of IDH Mutation and Its Marker 2-HG in Brain Tumor Patients
$375,455Hui Mao · Emory University · R01 · FY2015 · CA
MR Investigation of IDH Mutation and Its Marker 2-HG in Brain Tumor Patients
$375,455Hui Mao · Emory University · R01 · FY2016 · CA
Implications of a novel glioblastoma classification defined by miR-21-Sox2 status
$375,433Sadhan Majumder · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · NS
Targeting CCR2-expressing myeloid cells to overcome immune checkpoint inhibitor resistance in glioma
$375,159Jeffrey K Harrison · University Of Florida · R01 · FY2018 · NS
Development of murine glioblastoma model for oncolytic HSV therapy
$375,155Balveen Kaur · Augusta University · R61 · FY2025 · NS
Clinicopathologic and Genetic Profiling through Machine Learning and Natural Language Processing for Precision Lung Cancer Management
$375,150Saeed Hassanpour · Dartmouth College · R01 · FY2020 · CA
Clinicopathologic and Genetic Profiling through Machine Learning and Natural Language Processing for Precision Lung Cancer Management
$375,150Saeed Hassanpour · Dartmouth College · R01 · FY2019 · CA
Exploiting Pyrimidine Nucleotide Synthesis Dependence for IDH Mutant Glioma Therapy
$375,150Samuel Kent McBrayer · Ut Southwestern Medical Center · R01 · FY2025 · CA